Cytoadherence characteristics of Plasmodium falciparum isolates in Thailand using an in vitro human lung endothelial cells model

American Journal of Tropical Medicine and Hygiene

Volumn 62, Issue 1, 2000, Pages 38-44

  Traoré, Boubacar ^a   Muanza, Kabongo ^a   Looareesuwan, Sornchai ^b   Supavej, Suvanee ^b   Khusmith, Srisin ^b   Danis, Martin ^a   Viriyavejakul, Parnpen ^b   Gay, Frederick ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISIN; ARTEMISININ DERIVATIVE; ARTESUNATE; ATOVAQUONE; CD36 ANTIGEN; CHLOROQUINE; CHONDROITIN 4 SULFATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HALOFANTRINE; INTERCELLULAR ADHESION MOLECULE 1; MEFLOQUINE; QUININE; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ENDOTHELIUM; MAJOR CLINICAL STUDY; MALARIA; MALE; PHENOTYPE; PLASMODIUM FALCIPARUM; ROSETTE FORMATION; THAILAND;

ARTESUNATE; CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0034025958     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.62.38     Document Type: Article

References (36)

1. Berendt AR, Simmons D, Tansey J, Newbold C, Marsh K, 1989. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 341: 57-59.
2. Ockenhouse CF, Betageri R, Springer TA, Staunton DE, 1992. Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus. Cell 68: 63-69.
3. Barnwell JW, Asch AS, Nachman RL, Yamaya M, Aikawa M, Ingravallo P, 1989. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest 84: 765-772.
4. Ockenhouse CF, Tandon NN, Magowan C, Jamieson GA, Chulay JD, 1989. Identification of platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science 243: 1469-1471.
5. Ockenhouse CF, Tegoshi T, Maeno Y, Benjamin C, Ho M, Kan KE, Thway Y, Win K, Aikawa M, Lobbs RR, 1992. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med 176: 1183-1189.
6. Robert C, Pouvelle B, Meyer P, Muanza K, Fujioka H, Aikawa M. Scherf A, Gysin J, 1995. Chondroitin-4-sulfate (proteoglycan), a receptor for Plasmodium falciparum-infected erythrocyte adherence on brain microvascular endothelial cells. Res Immunol 146: 383-393.
7. Rogerson SJ, Chaiyaroj SC, Ken Ng, Reeder JC, Brown GV, 1995. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med 182: 15-20.
8. Roberts DD, Sherwood JA, Spitalnik SL, Panton LJ, Howard RJ, Dixit VM, Frazier WA, Miller LH, Ginsburg V, 1985. Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature 318: 64-66.
9. Muanza K, Gay F, Behr C, Scherf A, 1996. Primary culture of human lung endothelial cells: a useful in vitro model for studying Plasmodium falciparum-infected erythrocyte cytoadherence. Res Immunol 147: 149-163.
10. Warrell DA, Molyneux ME, Beales PF, 1990. Severe and complicated malaria. Trans R Soc Trop Med Hyg 84: 1-65.
11. Trager W, Jensen J, 1976. Human malaria parasites in continuous culture. Science 193: 673-675.
12. Pasvol G, Wilson JM, Smalley ME, Brown J, 1978. Separation of schizont-infected red cells of Plasmodium falciparum from human blood. Ann Trop Med Parasitol 72: 87-88.
13. Udeinya I, Schmidt J, Aikawa M, Miller L, Green I, 1981. Plasmodium falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells. Science 213: 555-557.
14. Carlson J, Holmquist G, Taylor DW, Perlmann P, Walhlgren M, 1990. Antibodies to a histidine rich protein (PfHRP1) disrupt spontaneously formed Plasmodium falciparum erythrocyte rosettes. Proc Natl Acad Sci USA 87: 2511-2515.
15. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710-718.
16. Gay F, Bustos D, Traoré B, Jardinel C, Southammavong M, Cicéron L, Danis M, 1997. In vivo response of Plasmodium falciparum to atovaquone and correlation with other antimalarials: comparison between African and Asian strains. Am J Trop Med Hyg 56: 315-317.
17. Ockenhouse CF, Ho M, Tandon NN, van Seventer GA, Shaw S, White NJ, Jamieson GA, Chulay JD, Webster HK, 1991. Molecular basis of sequestation in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis 164: 163-169.
18. Newbold C, Warm P, Black G, Berendt A, Craig A, Snow B, Msobo M, Peshu N, Marsh K, 1997. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg 57: 389-398.
19. Ho M, Singh B, Looareesuwan S, Davis TME, Bunnag D, White NJ, 1991. Clinical correlates of in vitro Plasmodium falciparum cytoadherence. Infect Immun 59: 873-878.
20. Fried M, Duffy, PE, 1996. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272: 1502-1504.
21. Prudhomme JG, Sherman IW, Land KM, Moses AV, Stengleins S, Nelson JA, 1996. Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cell. Int J Parasitol 26: 647-655.
22. Smith H, Nelson JA, Gahmberg CG, Crandall I, Sherman IW, 1992. Plasmodium falciparum: cytoadherence of malaria-infected erythrocytes to human brain capillary and umbilical vein endothelial cells, a comparative study of adhesive ligands. Exp Parasitol 75: 269-280.
23. Turner GDH, Morrison H, Jones M, Davis TME, Looareesuwan S, Buley ID, Gatter KC, Newbold CI, Pukritayakamee S, Nagachinta S, White NJ, and Berendt AR, 1994. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 145: 1057-1069.
24. Chaiyaroj SC, Angkasekwinai P, Buranakiti A, Looareesuwan S, Rogerson SJ, Brown GV, 1996. Cytoadherence characteristics of Plasmodium falciparum isolates from Thailand: evidence for chondroitin sulfate A as a cytoadherence receptor. Am J Trop Med Hyg 55: 76-80.
25. Ringwald P, Peyron F, Lepers JP, Rabarison P, Rakotomalala C, Razanamparany M, Rabodonirina M, Roux J, Le Bras J, 1993. Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines. Infect Immun 61: 5198-5204.
26. Treutiger CJ, Hedlund I, Helmby H, Carlson J, Jepson A, Twumasi P, Kwiatkowski D, Greenwood BM, Wahlgren M, 1992. Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg 46: 503-510.
27. Al-Yaman F, Genton B, Mokela D, Raiko A, Kati S, Rogerson S, Reeder J, Alpers M, 1995. Human cerebral malaria: lack of significant association between erythrocyte rosetting and disease severity. Trans R Soc Trop Med Hyg 89: 55-58.
28. Wahlgren M, Carlson J, Ruangjirachuporn W, Conway D, Helmby H, Martinez A, Patarroyo ME, Riley E, 1990. Geographical distribution of Plasmodium falciparum erythrocyte rosetting and frequency of rosetting antibodies in human sera. Am J Trop Med Hyg 43: 333-338.
29. Udomsangpetch R, Todd J, Carlson J, Greenwood BM, 1993. The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells. Am J Trop Med Hyg 48: 149-153.
30. Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanonta S, White NJ, 1994. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 84: 488-491.
31. ter Kuile FO, Dolan G, Nosten F, Edstein MD, Luxemburger C, Phaipun L, Chongsuphajaisiddhi T, Webster HK, White NJ, 1993. Halofantrine versus mefloquine for multidrug-resistant malaria. Lancet 341: 1044-1049.
32. Looareesuwan S, 1994. Overview of the clinical studies on artemisinin derivatives in Thailand. Trans R Soc Trop Med Hyg 88 (suppl 1): S9-S11.
33. Karbawang J, Tin T, Rimchala W, Sukontason K, Namsiripongpun V, Thanavibul A, Na-Bangchang K, Laothavorn P, Bunnag D, Harinasuta T, 1995. Comparison of artemether and quinine in the treatment of severe falciparum malaria in southeast Thailand. Trans R Soc Trop Med Hyg 89: 668-671.
34. Udomsangpetch R, Pipitaporn B, Krishna S, Angus B, Pukrittayakamee S, Bates I, Suputtamongkol Y, Kyle DE, White NJ, 1996. Antimalarial drugs reduce cytoadherence and rosetting of Plasmodium falciparum. J Infect Dis 173: 691-698.
35. Chotivanich KT, Pukrittayakamee S, Simpson JA, White NJ, Udomsangpetch R, 1998. Characteristics of Plasmodium vivax-infected erythrocyte rosettes. Am J Trop Med Hyg 59: 73-76.
36. Grau GE, Tacchini-Cottier F, Vesin C, Millon G, Lou JN, Juillard P, 1993. TNF-induced microvascular pathology: active role of platelets and importance of the LFA-1/ICAM-1 interaction. Eur Cytokine Network 4: 415-419.